Parasurgical therapy for keratoconus by riboflavin–ultraviolet type A rays induced cross‐linking of corneal collagen: Preliminary refractive results in an Italian study

PURPOSE: To assess the effectiveness of riboflavin–ultraviolet type A rays induced cross‐linking of corneal collagen in reducing progression of keratoconus and in improving visual acuity in patients with progressive keratoconus. SETTING: Department of Ophthalmology, Siena University, Siena, Italy. METHODS: This was a second‐phase prospective nonrandomized open study. Starting in September 2004, 10 eyes of 10 patients (mean age 31.4 years) with bilateral keratoconus were treated by combined riboflavin–ultraviolet type A rays (UVA) collagen cross‐linking. Radiant energy was 3 mW/cm2 or 5.4 joule/cm2 for a 30‐minute exposure at 1 cm from the corneal apex. A complete ophthalmologic examination (uncorrected visual acuity [UCVA], sphere spectacles corrected visual acuity (SSCVA), best spectacle‐corrected visual acuity [BSCVA]) was performed. Patients had corneal computerized topographic examination, linear scan optical tomography, endothelial cell count, ultrasound pachometry, intraocular pressure (IOP) evaluation, and HRT II system confocal microscopy at 1, 2, 3, and 6 months. After treatment, eyes were medicated and dressed with a soft contact lens. RESULTS: Comparative preoperative and postoperative results showed increases of 3.6 lines for UCVA (P = .0000112), 1.85 lines for SSCVA (P = .00065), and 1.66 lines for BSCVA (P = .00071). Topographic analysis showed a mean K reduction of 2.1 ± 0.13 diopters (D) in the central 3.0 mm. Statistical analysis of IOP and endothelial cell count did not show significant differences. Topo‐aberrometric analysis findings of corneal symmetry showed a trend toward increasing corneal symmetry with a major reduction in asymmetry between vertical hemimeridians. CONCLUSIONS: Refractive results showed a reduction of about 2.5 D in the mean spherical equivalent, topographically confirmed by the reduction in mean K. Results of surface aberrometric analysis showed improvement in morphologic symmetry with a significant reduction in comatic aberrations.

[1]  A. Nesburn,et al.  Abnormalities of the Extracellular Matrix in Keratoconus Corneas , 1997, Cornea.

[2]  J. Sugar,et al.  Expression of type XII collagen and hemidesmosome-associated proteins in keratoconus corneas , 2001, Current eye research.

[3]  T. Seiler,et al.  Endothelial cell damage after riboflavin–ultraviolet‐A treatment in the rabbit , 2003, Journal of cataract and refractive surgery.

[4]  G. Kymionis,et al.  Management of keratoconus with Intacs. , 2003, American journal of ophthalmology.

[5]  S. Wilson,et al.  Keratocyte apoptosis: implications on corneal wound healing, tissue organization, and disease. , 1998, Investigative ophthalmology & visual science.

[6]  Hamza N Khan,et al.  Reversibility and exchangeability of intrastromal corneal ring segments , 2002, Journal of cataract and refractive surgery.

[7]  A. Proia,et al.  Histopathological Variation in Keratoconus , 1992, Cornea.

[8]  T. Seiler,et al.  Stress‐strain measurements of human and porcine corneas after riboflavin–ultraviolet‐A‐induced cross‐linking , 2003, Journal of cataract and refractive surgery.

[9]  T. Seiler,et al.  Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. , 2003, American journal of ophthalmology.

[10]  G. Seigel,et al.  Evidence of Apoptotic Cell Death in Keratoconus , 2002, Cornea.

[11]  J. T. Ernest,et al.  Photodynamic Biologic Tissue Glue , 1994, Cornea.

[12]  C. Skorpik,et al.  Altered Organization of Collagen in the Apex of Keratoconus Corneas , 1998, Ophthalmic Research.

[13]  A. Daxer,et al.  Collagen fibrils in the human corneal stroma: structure and aging. , 1998, Investigative ophthalmology & visual science.

[14]  E Aine,et al.  The immunohistochemical composition of corneal basement membrane in keratoconus. , 1997, Current eye research.

[15]  B. Cochener,et al.  INTACS inserts for treating keratoconus: one-year results. , 2001, Ophthalmology.